Identification of heat shock protein 32 (Hsp32) as a novel survival factor

Department of Internal Medicine I, Division of Hematology & Hemostaseology, Graduate School of Medical Sciences, Kumamoto University, Japan.
Blood (Impact Factor: 10.45). 08/2007; 110(2):661-9. DOI: 10.1182/blood-2006-10-054411
Source: PubMed


Systemic mastocytosis (SM) is a myeloid neoplasm characterized by increased survival and accumulation of neoplastic mast cells (MCs). In most patients, the D816V-mutated variant of KIT is detectable. We report here that heat shock protein 32 (Hsp32), also known as heme oxygenase-1 (HO-1), is a novel KIT-inducible survival factor in neoplastic MCs. As assessed by reverse transcription-polymerase chain reaction (RT-PCR), immunocytochemistry, and Western blotting, the KIT D816V(+) MC line HMC-1.2 as well as highly enriched primary neoplastic MCs were found to express Hsp32 mRNA and the Hsp32 protein. Moreover, KIT D816V and stem cell factor (SCF)-activated wild-type KIT were found to induce Hsp32 promoter activity, expression of Hsp32 mRNA, and expression of the Hsp32 protein in Ba/F3 cells. Correspondingly, the KIT D816V-targeting drug PKC412 decreased the expression of Hsp32 as well as proliferation/survival in neoplastic MCs. The inhibitory effects of PKC412 on the survival of HMC-1.2 cells were counteracted by the HO-1 inductor hemin or lentiviral-transduced HO-1. Moreover, 2 Hsp32-targeting drugs, pegylated zinc protoporphyrin (PEG-ZnPP) and styrene maleic acid copolymer micelle-encapsulated ZnPP (SMA-ZnPP), were found to inhibit proliferation and to induce apoptosis in neoplastic MCs. Furthermore, both drugs were found to cooperate with PKC412 in producing growth inhibition. Together, these data show that Hsp32 is an important survival factor and interesting new therapeutic target in neoplastic MCs.

Download full-text


Available from: Anja Vales, Feb 09, 2015
  • Source
    • "This contrasts with a previous study using immunohistochemistry which indicated that hsp32 was up-regulated in prostate cancer tissue (Maines and Abrahamsson 1996). However, because it was observed to be widely expressed it could act as a pro-survival protein, as it may in mastocytosis (Kondo et al. 2007). Up-regulation of hsp32 expression has been shown to result in increased proliferation of melanoma cell lines and, compared with wild type cell lines, to significantly reduce survival time in mice (Was et al. 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Heat shock proteins (hsps) have been studied in numerous cancer types, but a clear view of their clinical relevance in melanoma remains elusive. Therefore, the aim of this study was to investigate the expression of hsps in melanoma with respect to patient clinical parameters. Using Western immunoblotting, hsps 90, 70, 60, 40 and 32 were observed to be widely expressed in metastatic melanomas (n = 31), while immunofluorescence demonstrated that in the majority of samples these hsps, apart from hsp32, were increased in expression in melanoma cells compared with surrounding non-melanoma cells in situ (n = 8). Correlating hsp expression with patient clinical parameters indicated that greater hsp90 (P < 0.02) and hsp40 (P < 0.03) expression correlated with advanced stage (stage III Vs stage IV), while in the case of hsp40, this was additionally associated with reduced patient survival (P < 0.05). In contrast, higher hsp32 expression was associated with improved patient survival (P < 0.007). On the other hand, the expression of the other hsps did not correlate with any obtainable patient clinical parameters. This study provides further evidence for the importance of hsps in melanoma and for their use as therapeutic targets and biomarkers, but larger-scale follow-up studies are required to confirm these results.
    Full-text · Article · Aug 2012 · Cell Stress and Chaperones
  • Source
    • "HSPs play important roles in folding, intracellular localization, and degradation of cellular proteins, but the cellular role of HSPs in cancers is not completely understood. However, some reports suggest that particularly high HSP 27, 32, 70 and 90 expression levels are associated with a poor prognosis and drug resistance for certain cancers, including carcinomas of the stomach, liver, and prostate, and also osteosarcomas (Kondo et al., 2007; Glaessgen et al., 2008; Banerji, 2009). Inhibition of these proteins is associated with good response in cancer cells. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Possible synergistic cytotoxic and apoptotic effects of gossypol with zoledronic acid on DU-145 cells were explored, along with the rationale behind any observed synergism due to the different apoptotic proteins involved. XTT cell proliferation assay was used to assess the cytotoxicity, and DNA fragmentation and caspase 3/7 activity were measured to verify apoptosis. Human Apoptosis Array was used to evaluate apoptotic proteins. The synergistic cytotoxic combination treatment had a versatile effect on apoptotic proteins, through inhibition of anti-apoptotic proteins (including cIAP-1, cIAP-2, survivin, livin, claspin, p53, p21, PON-2 and heat shock proteins) and concurrently the induction of pro-apoptotic proteins (Bad, Bax, Fas, FADD, cleaved caspase-3 and p27). Both drugs had a minimal toxicity profile comparing to cytotoxic agents. Combination treatments targeting many pivotal apoptosis-related proteins may be a rationale option for treatment of prostate cancer.
    Full-text · Article · Sep 2009 · Cell Biology International
  • Source
    • "A. K. Iyer et al. 502 mentioned above; the relative importance of each for the overall tumor response has yet to be fully defined. From the results, however, it seems clear that the combination of all these mechanisms does have a prominent effect on tumor cell killing as reported previously (Fang et al. 2004; Kondo et al. 2007; Regehly et al. 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Polymeric micelles of zinc protoporphyrin (ZnPP) with water soluble biocompatible and amphiphilic polymer, polyethylene glycol (PEG) demonstrated unique characteristics to target tumor tissues selectively based on the enhanced permeability and retention (EPR) effect. The micellar macromolecular drug of ZnPP (SMA-ZnPP and PEG-ZnPP) previously showed notable anticancer activity as a consequence of selective tumor targeting ability and its potent HO-1 inhibitory potential, resulting in suppressed biliverdin/bilirubin production in tumors thereby leading to oxystress induced tumor cell killing. Furthermore, recent findings also showed that ZnPP efficiently generated reactive singlet oxygen under illumination of visible light, laser, or xenon light source, which could augment its oxystress induced cell killing abilities. In the present paper, we report the synergistic effects of light induced photosensitizing capabilities and HO-1 inhibitory potentials of these unique micelles when tested in vitro and in vivo on tumor models under localized, mild illumination conditions using a tungsten-xenon light source. The results indicate that these water soluble polymeric micelles of ZnPP portend to be promising candidates for targeted chemotherapy as well as photodynamic therapy against superficial tumors as well as solid tumors located at light penetrable depths.
    Full-text · Article · Aug 2007 · Journal of Drug Targeting
Show more